Search Results - Machálková, Jana

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli

    High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli by Krahulec, Ján, Hyršová, Marcela, Pepeliaev, Stanislav, Jílková, Jana, Černý, Zbyněk, Machálková, Jana

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Alveolar antral artery: cone beam computed tomography study and clinical context

    Alveolar antral artery: cone beam computed tomography study and clinical context by Stanek, Ján, Machálková, Katerina, Stanková, Magdalena, Zapletalová, Jana, Kocurová, Tat'ána

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

    Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical... by Minarik, Jiri, Pika, Tomas, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pour, Ludek, Pavlicek, Petr, Mistrik, Martin, Brozova, Lucie, Krhovska, Petra, Machalkova, Katerina, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Stork, Martin, Bacovsky, Jaroslav, Capkova, Lenka, Sykora, Michal, Kessler, Petr, Stejskal, Lukas, Heindorfer, Adriana, Ullrychova, Jana, Skacel, Tomas, Maisnar, Vladimir, Hajek, Roman

    Published in BMC cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)

    Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results f... by Minarik, Jiri, Pika, Tomas, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pour, Ludek, Pavlicek, Petr, Mistrik, Martin, Brožová, Lucie, Krhovska, Petra, Machalkova, Katerina, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Stork, Martin, Bacovsky, Jaroslav, Capkova, Lenka, Sykora, Michal, Kessler, Petr, Stejskal, Lukáš, Heindorfer, Adriana, Ullrychova, Jana, Skacel, Tomas, Maisnar, Vladimir, Hajek, Roman

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Survival benefit of ixazomib, lenalidomide and dexamethasone in relapsed and refractory multiple myeloma patients in routine clinical practice

    Survival benefit of ixazomib, lenalidomide and dexamethasone in relapsed and refractory multiple myeloma patients in routine clinical practice by Minarik, Jiri, Pika, Tomas, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pour, Ludek, Pavlicek, Petr, Mistrik, Martin, Brozova, Lucie, Krhovska, Petra, Machalkova, Katerina, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Stork, Martin, Bacovsky, Jaroslav, Capkova, Lenka, Sykora, Michal, Kessler, Petr, Stejskal, Lukas, Heindorfer, Adriana, Ullrychova, Jana, Skacel, Tomas, Maisnar, Vladimir, Hajek, Roman

    Published in BMC cancer
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma

    Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma by Minarik, Jiri, Pika, Tomas, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pour, Ludek, Pavlicek, Petr, Mistrik, Martin, Brozova, Lucie, Krhovska, Petra, Machalkova, Katerina, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Štork, Martin, Bacovsky, Jaroslav, Capkova, Lenka, Sykora, Michal, Kessler, Petr, Stejskal, Lukas, Heindorfer, Adriana, Ullrychova, Jana, Maisnar, Vladimir, Hajek, Roman

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (Rd) in Relapsed and Refractory Multiple Myeloma Patients in Routine Clinical Practice

    Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (Rd) in Relapsed and Refractory Multiple Myeloma Patients in Routine Clinical... by Minarik, Jiri, Pika, Tomas, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pour, Ludek, Pavlicek, Petr, Mistrik, Martin, Brozova, Lucie, Krhovska, Petra, Machalkova, Katerina, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Stork, Martin, Bacovsky, Jaroslav, Capkova, Lenka, Sykora, Michal, Kessler, Petr, Stejskal, Lukas, Heindorfer, Adriana, Ullrychova, Jana, Skacel, Tomas, Maisnar, Vladimir, Hajek, Roman

    Published in BMC Cancer
    Request full text
    Text Resource
    Save to List
    Saved in:

Search Tools: